Industry News
Nature Communications Medicine publishes positive, real-world data for tinnitus patients treated with unique, FDA approved stimulation device
Nature Communications Medicine has published the first peer reviewed, real-world analysis of U.S. patients treated with Lenire, the only FDA approved tinnitus treatment device of its kind. Results in the paper “Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for...
KARL STORZ acquisition of assets from Diaspective Vision
KARL STORZ is pleased to announce the acquisition of assets from Diaspective Vision, a Germany-based business that has driven innovations in the field of spectral camera solutions for medical applications since 2015. Employees from Diaspective Vision will join the KARL...
Oticon Medical Hosts Fifth Annual Good Vibrations Day
April 22, 2025. Gothenburg, Sweden. Oticon Medical is thrilled to announce the fifth annual Good Vibrations Day campaign, a month-long initiative dedicated to raising awareness about bone anchored hearing. Beginning 3rd April 2025, this campaign has been featuring various social...
Discover the future of reflux diagnostics in BIOHIT HealthCare’s webinar
Join BIOHIT HealthCare on the 14th of May 2025 for a live free webinar discussing Peptest®, our innovative non-invasive diagnostic tool for reflux. The session will be delivered by Dr Andrew Woodcock, Chief Scientific Officer at RD Biomed, who will...
KARL STORZ Introduces the Slimline C-MAC® S: A New Era in Airway Management
The family-owned MedTech company KARL STORZ has announced the worldwide launch of the Slimline C-MAC® S, a single-use video laryngoscope designed to enhance airway management. This innovative tool is built to the same high-quality standards as all products from the...
Join BIOHIT HealthCare at the ENT UK and YCOHNS 2025 Annual Meeting
BIOHIT HealthCare will be attending this year’s ENT UK and YCOHNS Annual Meeting on the 26th and 27th of June. These conferences will take place back-to-back at IET Birmingham, bringing together leading experts in ENT surgery and otorhinolaryngology to discuss...
Interacoustics introduces Equinox Evo & Touch Keyboard
Interacoustics are excited to announce the introduction of the Equinox Evo & Touch Keyboard: a game-changing audiometric solution that will enhance hearing test flows. The Equinox Evo is a clinical PC-based audiometer designed to evolve with the demands and growth...
Leightons and The Hearing Care Partnership Opens Registration for Groundbreaking New Clinical Conference: Oxygen 2025
Leightons Opticians & Hearing Care is excited to announce that registration is now open for Oxygen 2025, a pioneering clinical conference taking place on the 9th and 10th of May 2025. This highly anticipated event, hosted by the leading independent,...
Neuromod closes €10 million financing to accelerate commercialisation
Neuromod, an Irish medical device company specialising in tinnitus, has closed a €10 million equity financing deal in a Series B fundraising expansion to expand the availability of tinnitus treatment device, Lenire. Financing was oversubscribed and led by existing investors...
UK clinics providing Lenire tinnitus treatment device double in latest expansion
Neuromod Devices, the medical device company that specialises in tinnitus treatment, has announced they are partnering with four UK clinics to expand the availability of Lenire®, the clinically proven tinnitus treatment device. Tinnitus, which is commonly known as “ringing in...
Soluvos Medical: exclusive A.R.C. Laser partner in the UK from 1 March 2025
Soluvos Medical is delighted to announce that, as of 1 March 2025, they will be the exclusive A.R.C. Laser partner in the UK. Driven by a commitment to clinical excellence and innovation, Soluvos Medical is proud to deliver state-of-the-art laser...
Landmark study at Homerton University Hospital confirms GastroPanel®’s diagnostic accuracy
BIOHIT HealthCare is pleased to announce that a clinical study conducted by Homerton University Hospital NHS Foundation Trust, London, has confirmed the diagnostic accuracy of GastroPanel in identifying gastric cancer risk in patients with upper abdominal complaints. This study demonstrated...
